CORVEL CORP (CRVL)
US2210061097 - Common Stock
We assign a fundamental rating of 6 out of 10 to CRVL. CRVL was compared to 117 industry peers in the Health Care Providers & Services industry. CRVL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CRVL is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CRVL was profitable.
CRVL had a positive operating cash flow in the past year.
CRVL had positive earnings in each of the past 5 years.
CRVL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CRVL's Return On Assets of 16.85% is amongst the best of the industry. CRVL outperforms 96.55% of its industry peers.
With an excellent Return On Equity value of 32.11%, CRVL belongs to the best of the industry, outperforming 93.97% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 29.09%, CRVL belongs to the top of the industry, outperforming 99.14% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRVL is significantly above the industry average of 8.60%.
The last Return On Invested Capital (29.09%) for CRVL is above the 3 year average (24.78%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.85% | ||
| ROE | 32.11% | ||
| ROIC | 29.09% |
ROA(3y)14.59%
ROA(5y)13.97%
ROE(3y)28.38%
ROE(5y)26.82%
ROIC(3y)24.78%
ROIC(5y)23.05%
1.3 Margins
The Profit Margin of CRVL (9.70%) is better than 93.10% of its industry peers.
CRVL's Profit Margin has improved in the last couple of years.
CRVL has a Operating Margin of 12.29%. This is amongst the best in the industry. CRVL outperforms 90.52% of its industry peers.
CRVL's Operating Margin has improved in the last couple of years.
The Gross Margin of CRVL (22.02%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CRVL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.29% | ||
| PM (TTM) | 9.7% | ||
| GM | 22.02% |
OM growth 3Y4.73%
OM growth 5Y6.54%
PM growth 3Y4.9%
PM growth 5Y7.64%
GM growth 3Y1.19%
GM growth 5Y2.77%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRVL is creating value.
Compared to 1 year ago, CRVL has less shares outstanding
Compared to 5 years ago, CRVL has less shares outstanding
CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CRVL has an Altman-Z score of 16.76. This indicates that CRVL is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 16.76, CRVL belongs to the best of the industry, outperforming 99.14% of the companies in the same industry.
There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.76 |
ROIC/WACC3.11
WACC9.34%
2.3 Liquidity
A Current Ratio of 1.56 indicates that CRVL should not have too much problems paying its short term obligations.
CRVL has a Current ratio of 1.56. This is in the better half of the industry: CRVL outperforms 64.66% of its industry peers.
CRVL has a Quick Ratio of 1.56. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CRVL (1.56) is better than 69.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.56 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.71% over the past year.
Measured over the past years, CRVL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.05% on average per year.
The Revenue has grown by 9.79% in the past year. This is quite good.
Measured over the past years, CRVL shows a small growth in Revenue. The Revenue has been growing by 5.17% on average per year.
EPS 1Y (TTM)12.71%
EPS 3Y13.92%
EPS 5Y15.05%
EPS growth Q2Q3.13%
Revenue 1Y (TTM)9.79%
Revenue growth 3Y6.66%
Revenue growth 5Y5.17%
Revenue growth Q2Q12.77%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 55.24, which means the current valuation is very expensive for CRVL.
CRVL's Price/Earnings is on the same level as the industry average.
CRVL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.24 | ||
| Fwd PE | N/A |
4.2 Price Multiples
CRVL's Enterprise Value to EBITDA ratio is in line with the industry average.
CRVL's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 57.91 | ||
| EV/EBITDA | 32.78 |
4.3 Compensation for Growth
CRVL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.67
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CRVL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CORVEL CORP
NASDAQ:CRVL (4/26/2024, 7:00:00 PM)
After market: 238.64 0 (0%)238.64
+0.52 (+0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.08B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.24 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)3.67
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.85% | ||
| ROE | 32.11% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 12.29% | ||
| PM (TTM) | 9.7% | ||
| GM | 22.02% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.56 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)12.71%
EPS 3Y13.92%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.79%
Revenue growth 3Y6.66%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y